Evaluation of iron chelator administration, and cochlear implantation for s uperficial siderosis (ECHACISS)
Not Applicable
Recruiting
- Conditions
- superficial siderosis of CNS
- Registration Number
- JPRN-UMIN000021218
- Lead Sponsor
- Department of Neurology, Tokyo Medical and Dental University
- Brief Summary
Conclusions Deferiprone administration significantly improved radiological and clinical outcomes in patients with postoperative superficial siderosis. Earlier and longer courses of deferiprone could result in better patient prognosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
anaphylaxis to iron chelator patients receiving any drug having side effect of leukopenia pregnant person claustrophobia inadequate patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method hearing ability, cerebellar ataxia (SARA, ICARS), MRI findings, pyramidal sign, electrophysiological studies
- Secondary Outcome Measures
Name Time Method persistence rate of treatment, CSF findings, safety